These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3003376)

  • 1. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
    Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
    J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum to: Metabolomics of rhabdomyosarcoma cell during echovirus 30 infection.
    Tiwari S; Dhole TN
    Virol J; 2017 Sep; 14(1):182. PubMed ID: 28927425
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular receptor for Pixuna virus in chicken embryonic fibroblasts.
    Paglini G; Pereyra Edel C; Paglini S
    Med Microbiol Immunol; 2006 Jun; 195(2):85-92. PubMed ID: 16220309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.
    Stuart AD; Eustace HE; McKee TA; Brown TD
    J Virol; 2002 Sep; 76(18):9307-22. PubMed ID: 12186914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
    Shafren DR; Williams DT; Barry RD
    J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.
    Anderson DR; Carthy CM; Wilson JE; Yang D; Devine DV; McManus BM
    J Virol; 1997 Nov; 71(11):8841-5. PubMed ID: 9343244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
    Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
    J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and distribution of the receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in culture.
    Xu R; Crowell RL
    Virus Res; 1996 Dec; 46(1-2):157-70. PubMed ID: 9029788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.
    Shafren DR; Bates RC; Agrez MV; Herd RL; Burns GF; Barry RD
    J Virol; 1995 Jun; 69(6):3873-7. PubMed ID: 7538177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
    Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
    J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a monoclonal antibody which blocks vaccinia virus infection.
    Chang W; Hsiao JC; Chung CS; Bair CH
    J Virol; 1995 Jan; 69(1):517-22. PubMed ID: 7527087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells.
    Huber SA
    J Virol; 1994 Jun; 68(6):3453-8. PubMed ID: 7514674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice immunized with measles virus develop antibodies to a cell surface receptor for binding virus.
    Krah DL; Choppin PW
    J Virol; 1988 May; 62(5):1565-72. PubMed ID: 3357206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-protective monoclonal antibodies to bovine enterovirus-3 and partial or no activity against other serotypes.
    Teyssedou E; Magar R; Justewicz DM; Lecomte J
    J Virol; 1987 Jun; 61(6):2050-3. PubMed ID: 3033333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody identification of a 100-kDa membrane protein in HeLa cells and human spinal cord involved in poliovirus attachment.
    Shepley MP; Sherry B; Weiner HL
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7743-7. PubMed ID: 2845419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a YAC-1 mouse cell receptor for group B coxsackieviruses.
    Hsu KH; Crowell RL
    J Virol; 1989 Jul; 63(7):3105-8. PubMed ID: 2724420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and experimental aspects of viral myocarditis.
    Leslie K; Blay R; Haisch C; Lodge A; Weller A; Huber S
    Clin Microbiol Rev; 1989 Apr; 2(2):191-203. PubMed ID: 2650861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice.
    Blay R; Simpson K; Leslie K; Huber S
    Am J Pathol; 1989 Nov; 135(5):899-907. PubMed ID: 2573284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity of enterovirus subgroups.
    Auvinen P; Stanway G; Hyypiä T
    Arch Virol; 1989; 104(3-4):175-86. PubMed ID: 2539795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
    Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
    J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.